Company page
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. is a public company listed under the ticker PRAX, operating in the American market. The company has a market capitalization of approximately $7.87 billion. Praxis focuses on developing innovative therapies for patients with neurological diseases and psychiatric disorders.
- Ticker
- PRAX:NASDAQ
- Asset type
- Stock
- Market cap
- $7.87B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD